Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial
NEW YORK, NY, September 24, 2024 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share positive topline results from the Phase 3 PHOENYCS GO study evaluating the investigational therapy dapirolizumab pegol in people living with moderate-to-severe systemic lupus. Results of the Phase 3 PHOENYCS GO study were reported […] Read More